Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The mRNA vaccine development landscape for infectious diseases.
Kumar A, Blum J, Thanh Le T, Havelange N, Magini D, Yoon IK. Kumar A, et al. Among authors: yoon ik. Nat Rev Drug Discov. 2022 May;21(5):333-334. doi: 10.1038/d41573-022-00035-z. Nat Rev Drug Discov. 2022. PMID: 35149859 No abstract available.
Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection.
Salje H, Alera MT, Chua MN, Hunsawong T, Ellison D, Srikiatkhachorn A, Jarman RG, Gromowski GD, Rodriguez-Barraquer I, Cauchemez S, Cummings DAT, Macareo L, Yoon IK, Fernandez S, Rothman AL. Salje H, et al. Among authors: yoon ik. Nat Med. 2021 Aug;27(8):1395-1400. doi: 10.1038/s41591-021-01392-9. Epub 2021 Jun 24. Nat Med. 2021. PMID: 34168334 Free PMC article.
Immune correlates for dengue vaccine development.
Srikiatkhachorn A, Yoon IK. Srikiatkhachorn A, et al. Among authors: yoon ik. Expert Rev Vaccines. 2016;15(4):455-65. doi: 10.1586/14760584.2016.1116949. Epub 2015 Nov 24. Expert Rev Vaccines. 2016. PMID: 26560015 Free PMC article. Review.
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.
Clapham HE, Rodriguez-Barraquer I, Azman AS, Althouse BM, Salje H, Gibbons RV, Rothman AL, Jarman RG, Nisalak A, Thaisomboonsuk B, Kalayanarooj S, Nimmannitya S, Vaughn DW, Green S, Yoon IK, Cummings DA. Clapham HE, et al. Among authors: yoon ik. J Infect Dis. 2016 May 1;213(9):1428-35. doi: 10.1093/infdis/jiv759. Epub 2015 Dec 23. J Infect Dis. 2016. PMID: 26704615 Free PMC article.
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk.
Salje H, Cummings DAT, Rodriguez-Barraquer I, Katzelnick LC, Lessler J, Klungthong C, Thaisomboonsuk B, Nisalak A, Weg A, Ellison D, Macareo L, Yoon IK, Jarman R, Thomas S, Rothman AL, Endy T, Cauchemez S. Salje H, et al. Among authors: yoon ik. Nature. 2018 May;557(7707):719-723. doi: 10.1038/s41586-018-0157-4. Epub 2018 May 23. Nature. 2018. PMID: 29795354 Free PMC article.
Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development.
Salje H, Rodríguez-Barraquer I, Rainwater-Lovett K, Nisalak A, Thaisomboonsuk B, Thomas SJ, Fernandez S, Jarman RG, Yoon IK, Cummings DA. Salje H, et al. Among authors: yoon ik. PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2952. doi: 10.1371/journal.pntd.0002952. eCollection 2014 Jun. PLoS Negl Trop Dis. 2014. PMID: 24967885 Free PMC article.
Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.
Buddhari D, Aldstadt J, Endy TP, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C, Nisalak A, Khuntirat B, Jarman RG, Fernandez S, Thomas SJ, Scott TW, Rothman AL, Yoon IK. Buddhari D, et al. Among authors: yoon ik. PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3230. doi: 10.1371/journal.pntd.0003230. eCollection 2014 Oct. PLoS Negl Trop Dis. 2014. PMID: 25329173 Free PMC article.
154 results